相关实验视频
Updated: Jan 13, 2026

05:21
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
Published on: November 1, 2024
1.2K
奇州迪黄药在与年龄相关的干眼疾病中调节补充系统:通过临床-奥米克-动物集成进行三方验证
Lihao Chen1, Jun Peng2, Genyan Qin3
1Hunan University of Chinese Medicine, Changsha, Hunan 410208, China; National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.
Journal of ethnopharmacology
|January 11, 2026
概括
齐祖迪黄药 (QJDHW) 通过调节补体系统,有效治疗与年龄相关的干眼疾病 (DED). 这种传统的中医药可以减少炎症,改善眼睛表面的健康状况,提供一种新的治疗方法.
科学领域:
- 综合医学是一个整体的医学.
- 眼科医生 眼科 眼科
- 蛋白质组学是指蛋白质组学.
背景情况:
- 与年龄相关的干眼疾病 (DED) 涉及眼膜不稳定性和眼表面失生症,目前的治疗方法缺乏持续的疗效.
- 传统中医 (TCM) 为与年龄相关的DED提供了多目标干预措施,但Qiju Dihuang Pill (QJDHW) 的分子机制需要阐明.
研究的目的:
- 为了研究与年龄相关的DED的蛋白质组概况.
- 探索QJDHW在治疗与年龄相关的DED中的特定机制.
主要方法:
- 在30名参与者 (15个与年龄相关的DED,15个对照组) 中进行了综合临床表型,omics分析和草药干预.
- 使用数据独立获取 (DIA) 的血清蛋白质组分析.
- 建立了一个与年龄相关的DED大鼠模型,以评估QJDHW对眼睛表面,认知功能和分子标记物的影响 (补充调节者C3,C5,CFHR3,CD59;炎症标记者IL-6).
主要成果:
- 蛋白质组分析确定了丰富的补充和凝血级联通路,其中包括C5,CD59和CFHR3.3等差异性蛋白质.
- 高剂量的QJDHW显著改善了液分泌,膜稳定性和眼睛表面形态.
- QJDHW上调的补充抑制剂 (CFHR3,CD59) 和下调的补充激活剂 (C3,C5) 和IL-6.
结论:
- QJDHW通过调节补体激活抑制系统和抑制C3/C5介导的炎症来治疗与年龄相关的DED.
- 这项研究为TCM在治疗与年龄相关的眼部疾病方面的整体方法提供了分子证据.
相关概念视频
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K

